非洲药物难治性癫痫的外科治疗:一项系统综述
该系统综述纳入来自6个非洲国家的9项研究、共498例患者,评估药物难治性癫痫的手术治疗情况。术后80.6%的患者达到Engel I级结局,长期随访(1至5年)中70.3%维持Engel I级,手术并发症报告率为8.8%。
要点
- 术后80.6%患者达Engel I级,长期随访70.3%维持Engel I级。
- 颞叶切除术是最常实施的手术(59.6%),其次为病灶切除术(9.6%)。
- 手术并发症报告率为8.8%。
核心结论
- 研究结果表明癫痫外科在非洲具有疗效和长期获益,该地区癫痫是重大公共卫生挑战。
- 术后高无发作率和发作频率降低突显其改善非洲药物难治性癫痫患者生活质量的潜力。
研究设计与样本
- 系统综述,遵循PRISMA指南,检索PubMed、Google Scholar、Embase和Web of Science。
- 纳入9项研究,共498例患者,来自6个非洲国家(埃及、肯尼亚、摩洛哥、南非、突尼斯和乌干达)。
- 纳入文章的平均MINORS评分为9.6 ± 1.6。
主要发现
- 患者平均年龄24.9岁(95% CI:18.9-30.8岁),男性占53.4%。
- 平均癫痫起病年龄10.4岁(95% CI:6.1-14.7岁)。
- 多数患者为局灶性起病发作(73.1%),最常见的报告危险因素为头部外伤(33.1%)。
- 主要病因依次为海马硬化(66.8%,95% CI:42.7-91)、微发育不良(26.7%,95% CI:20.7-32.7)和脑肿瘤(22.3%,95% CI:6.4-38.2)。
- 病灶主要位于左半球(61.9%,95% CI:26.7-97.1),54.8%的病例累及颞叶(95% CI:28.7-80.8)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Nearly one-third of individuals with epilepsy have drug-resistant epilepsy, treated most effectively with surgery. This study aims to discuss the demographic profile, surgical access, and strategies used in drug-resistant epilepsy in Africa. METHODS: A systematic review was performed using PubMed, Google Scholar, Embase, and Web of Science in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. RESULTS: Nine studies encompassing 498 patients from 6 African countries (Egypt, Kenya, Morocco, South Africa, Tunisia, and Uganda) were included. The mean Methodological Index for Non-Randomized Studies score for these articles was 9.6 ± 1.6. The average patient age was 24.9 years (95% CI: 18.9-30.8 years), with a male predominance of 53.4%. The average age of seizure onset was 10.4 years (95% CI: 6.1-14.7 years). Most patients experienced focal onset seizures (73.1%), with head trauma (33.1%) being the most reported risk factor. The predominant etiologies were hippocampal sclerosis (66.8%, 95% CI: 42.7-91), microdysgenesis (26.7%, 95% CI: 20.7-32.7), and brain tumors (22.3%, 95% CI: 6.4-38.2). Lesions were primarily located in the left hemisphere (61.9%, 95% CI: 26.7-97.1), with temporal lobe involvement in 54.8% of cases (95% CI: 28.7-80.8). Temporal lobectomy was the most frequently performed surgery (59.6%), followed by lesionectomy (9.6%). Postoperatively, 80.6% of patients achieved Engel class I outcomes, indicating seizure freedom, and long-term follow-up (1 to 5 years) showed that 70.3% maintained Engel class I outcomes. Surgical complications were reported in 8.8% of cases. CONCLUSION: These findings demonstrate the efficacy and long-term benefits of epilepsy surgery in Africa, where epilepsy is a significant public health challenge. The high rates of seizure freedom and reduced seizure frequency from surgery highlight its potential to improve the quality of life for individuals with drug-resistant epilepsy in Africa.
引用
- Darko K, Tenkorang PO, Asiedu O, et al. Epilepsy Surgery for Drug-Resistant Epilepsy in Africa: A Systematic Review. Neurosurgery. 2024. PMID: 39665528. doi:10.1227/neu.0000000000003307
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。